View in EDS

Estimating the Real Option Value of Osimertinib Compared to Standard EGFR-TKI in the Treatment of Advanced NSCLC in the United States.

Saved in:
Bibliographic Details
Title: Estimating the Real Option Value of Osimertinib Compared to Standard EGFR-TKI in the Treatment of Advanced NSCLC in the United States.
Authors: Adjei K; Economic, Social, and Administrative Pharmacy (ESAP), College of Pharmacy and Pharmaceutical Sciences, Florida A&M University, Tallahassee, FL, USA., Diaby V; Otsuka Pharmaceutical Companies, Gainesville, FL, USA., Li M; Center for the Evaluation of Value and Risk in Health, Tufts Medical Center, Boston, MA, USA., Sherbeny F; Economic, Social, and Administrative Pharmacy (ESAP), College of Pharmacy and Pharmaceutical Sciences, Florida A&M University, Tallahassee, FL, USA., Suther S; Economic, Social, and Administrative Pharmacy (ESAP), College of Pharmacy and Pharmaceutical Sciences, Florida A&M University, Tallahassee, FL, USA., Ali AA; Economic, Social, and Administrative Pharmacy (ESAP), College of Pharmacy and Pharmaceutical Sciences, Florida A&M University, Tallahassee, FL, USA. askal.ali@famu.edu.
Source: Clinical drug investigation [Clin Drug Investig] 2026 Jul; Vol. 46 (7), pp. 721-732. Date of Electronic Publication: 2026 May 29.
Publication Type: Journal Article; Comparative Study
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9504817 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1918 (Electronic) Linking ISSN: 11732563 NLM ISO Abbreviation: Clin Drug Investig Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42213399
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Estimating the Real Option Value of Osimertinib Compared to Standard EGFR-TKI in the Treatment of Advanced NSCLC in the United States.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Adjei+K%22">Adjei K</searchLink>; Economic, Social, and Administrative Pharmacy (ESAP), College of Pharmacy and Pharmaceutical Sciences, Florida A&M University, Tallahassee, FL, USA.<br /><searchLink fieldCode="AU" term="%22Diaby+V%22">Diaby V</searchLink>; Otsuka Pharmaceutical Companies, Gainesville, FL, USA.<br /><searchLink fieldCode="AU" term="%22Li+M%22">Li M</searchLink>; Center for the Evaluation of Value and Risk in Health, Tufts Medical Center, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Sherbeny+F%22">Sherbeny F</searchLink>; Economic, Social, and Administrative Pharmacy (ESAP), College of Pharmacy and Pharmaceutical Sciences, Florida A&M University, Tallahassee, FL, USA.<br /><searchLink fieldCode="AU" term="%22Suther+S%22">Suther S</searchLink>; Economic, Social, and Administrative Pharmacy (ESAP), College of Pharmacy and Pharmaceutical Sciences, Florida A&M University, Tallahassee, FL, USA.<br /><searchLink fieldCode="AU" term="%22Ali+AA%22">Ali AA</searchLink>; Economic, Social, and Administrative Pharmacy (ESAP), College of Pharmacy and Pharmaceutical Sciences, Florida A&M University, Tallahassee, FL, USA. askal.ali@famu.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229504817%22">Clinical drug investigation</searchLink> [Clin Drug Investig] 2026 Jul; Vol. 46 (7), pp. 721-732. <i>Date of Electronic Publication: </i>2026 May 29.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Comparative Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>9504817 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-1918 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211732563%22">11732563 </searchLink><i>NLM ISO Abbreviation: </i>Clin Drug Investig <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42213399
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40261-026-01560-0
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 721
    Titles:
      – TitleFull: Estimating the Real Option Value of Osimertinib Compared to Standard EGFR-TKI in the Treatment of Advanced NSCLC in the United States.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Adjei K
      – PersonEntity:
          Name:
            NameFull: Diaby V
      – PersonEntity:
          Name:
            NameFull: Li M
      – PersonEntity:
          Name:
            NameFull: Sherbeny F
      – PersonEntity:
          Name:
            NameFull: Suther S
      – PersonEntity:
          Name:
            NameFull: Ali AA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2026 Jul
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1179-1918
          Numbering:
            – Type: volume
              Value: 46
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Clinical drug investigation
              Type: main
ResultId 1